Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203788 · ClinicalTrials.gov registry record · Phase 4
Improving Work Outcome in People With Recent-onset Schizophrenia
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 87
- Enrollment target
NCT00203788: Completed Phase 4 study, sponsored by University of California, Los Angeles.
NCT00203788 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 87 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00203788, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of combining antipsychotic medication with Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or Brokered Vocational Rehabilitation in facilitating the search for appropriate work or schooling and maintaining work or school activities in people with recent-onset schizophrenia.
Interventions
- BEHAVIORAL Individual Placement and Support
- BEHAVIORAL Workplace Fundamentals Module
- BEHAVIORAL Brokered Vocational Rehabilitation
- DRUG Oral risperidone
- BEHAVIORAL Skills training group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 1999-05 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
What the finished NCT00203788 record still lists
NCT00203788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 5 interventions - of which Individual Placement and Support is the first listed.
NCT00203788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00203788 about?
NCT00203788 is a clinical study titled "Improving Work Outcome in People With Recent-onset Schizophrenia". This study will determine the effectiveness of combining antipsychotic medication with Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or Brokered Vocational Rehabilitation in facilitating the search for appropriate work or schooling and maintaining w...
What is the current status of trial NCT00203788?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 87 participants. The study started on 1999-05. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00203788?
The interventions under investigation include: Individual Placement and Support (BEHAVIORAL), Workplace Fundamentals Module (BEHAVIORAL), Brokered Vocational Rehabilitation (BEHAVIORAL), Oral risperidone (DRUG), Skills training group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00203788?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00203788's enrollment target sits among peer trials
87 923rd of 2000 higher than 1,075 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia